Is CRYO or ORCC a better dividend investment in 2026?

CRYO currently yields 2000000.00% with a 5% 5-year dividend growth rate. ORCC yields 9.79% with 5% growth. The better choice depends on your goal: CRYO offers higher current income.

What is the dividend yield difference between CRYO and ORCC?

CRYO has a forward dividend yield of 2000000.00% ($2.00/share annually). ORCC yields 9.79% ($1.32/share annually). The yield gap is 1999990.21 percentage points.

Home › Compare › CRYO vs ORCC

CRYO vs ORCC: Dividend Comparison 2026

CRYO yields 2000000.00% · ORCC yields 9.79%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 CRYO wins by $4.879226400974806e+39M in total portfolio value

INVESTMENT

TIME HORIZON10 years

CRYO

● Live price

2000000.00%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$4.879226400974806e+39M

Annual income

$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00

Full CRYO calculator →

ORCC

● Live price

9.79%

Share price

$13.48

Annual div

$1.32

5Y div CAGR

-50%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$21.4K

Annual income

$1.04

Full ORCC calculator →

Portfolio growth — CRYO vs ORCC

📍 CRYO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	CRYO	ORCC
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, CRYO + ORCC cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

CRYO pays

ORCC pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CRYO

Annual income on $10K today (after 15% tax)

$170,000,000.00/yr

After 10yr DRIP, annual income (after tax)

$4,146,934,558,431,324,500,000,000,000,000,000,000,000,000,000.00/yr

ORCC

Annual income on $10K today (after 15% tax)

$832.34/yr

After 10yr DRIP, annual income (after tax)

$0.88/yr

At 15% tax rate, CRYO beats the other by $4,146,934,558,431,324,500,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CRYO + ORCC for your $10,000?

CRYO: 50%ORCC: 50%

100% ORCC50/50100% CRYO

Portfolio after 10yr

$2.439613200487403e+39M

Annual income

$2,439,373,269,665,485,000,000,000,000,000,000,000,000,000,000.00/yr

Blended yield

99.99%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on ORCC right now

CRYO

No analyst data

Altman Z

-41.2

Piotroski

3/9

ORCC

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$16.00

+18.7% upside vs current

Range: $16.00 — $16.00

Altman Z

0.5

Piotroski

5/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CRYO buys

ORCC buys

No recent congressional trades found for CRYO or ORCC in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricCRYOORCC

Forward yield	2000000.00% ✓	9.79%
Annual dividend / share	$2.00 ✓	$1.32
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0% ✓	-50%
Portfolio after 10y	$4.879226400974806e+39M	$21.4K ✓
Annual income after 10y	$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00 ✓	$1.04
Total dividends collected	$4.879195005460081e+39M ✓	$1.0K
Payment frequency	quarterly	quarterly
Sector	Stock	BDC

Year-by-year: CRYO vs ORCC ($10,000, DRIP)

Year	CRYO Portfolio	CRYO Income/yr	ORCC Portfolio	ORCC Income/yr	Gap
1← crossover	$200,010,700	$200,000,000.00	$11,190	$489.61	+$200.00M → CRYO
2	$3,738,731,768,458	$3,738,517,757,009.35	$12,229	$256.01	+$3738731.76M → CRYO
3	$65,315,062,866,930,490	$65,311,062,423,938,240.00	$13,216	$130.74	+$65315062866.92M → CRYO
4	$1,066,400,830,062,625,000,000	$1,066,330,942,945,357,500,000.00	$14,207	$66.02	+$1066400830062625.00M → CRYO
5	$16,272,182,796,453,826,000,000,000	$16,271,041,747,565,660,000,000,000.00	$15,234	$33.17	+$16272182796453826560.00M → CRYO
6	$232,054,240,113,661,900,000,000,000,000	$232,036,828,878,069,680,000,000,000,000.00	$16,317	$16.62	+$2.3205424011366188e+23M → CRYO
7	$3,092,799,066,104,688,500,000,000,000,000,000	$3,092,550,768,067,767,400,000,000,000,000,000.00	$17,468	$8.32	+$3.0927990661046884e+27M → CRYO
8	$38,524,105,697,352,694,000,000,000,000,000,000,000	$38,520,796,402,351,967,000,000,000,000,000,000,000.00	$18,695	$4.16	+$3.8524105697352695e+31M → CRYO
9	$448,468,826,014,798,700,000,000,000,000,000,000,000,000	$448,427,605,221,702,600,000,000,000,000,000,000,000,000.00	$20,006	$2.08	+$4.484688260147987e+35M → CRYO
10	$4,879,226,400,974,806,000,000,000,000,000,000,000,000,000,000	$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00	$21,407	$1.04	+$4.879226400974806e+39M → CRYO

CRYO vs ORCC: Complete Analysis 2026

CRYO — Stock

American CryoStem Corporation develops, markets, and licenses adipose tissue derived technologies for use in the fields of Regenerative and Personalized Medicine. The company's products include CELLECT collection, transportation, and storage system, which is a solution for physicians to collect and deliver tissue samples; ATGRAFT adipose tissue storage service, a fat collection, processing, and storage solution that enables physicians to provide their patients with tissue products and cell storage options; and ATCELL adipose derived stem cells. It also offers ACSelerat cell culture media products for growing human stromal cells. In addition, the company, provides contract manufacturing services for Autokine-CM, an anti-aging topical formulation; and autologous skin care product line. American CryoStem Corporation was founded in 1987 and is based in Eatontown, New Jersey.

Full CRYO Calculator →

ORCC — BDC

Owl Rock Capital Corporation is a business development company. The fund makes investments in senior secured or unsecured loans, subordinated loans or mezzanine loans and also considers equity-related securities including warrants and preferred stocks also pursues preferred equity investments and common equity investments. Within private equity, it seeks to invest in growth, acquisitions, market or product expansion, refinancings and recapitalizations. It seeks to invest in middle market companies based in the United States, with EBITDA between $10 million and $250 million annually and/or annual revenue of $50 million and $2.5 billion at the time of investment.

Full ORCC Calculator →

📬

Get this CRYO vs ORCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CRYO vs SCHD CRYO vs JEPI CRYO vs O CRYO vs KO CRYO vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.